The stock has a 36-month beta value of 1.37. Opinions on the stock are mixed, with 4 analysts rating it as a “buy,” 3 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for OPRX is 15.88M, and at present, short sellers hold a 6.02% of that float. On November 14, 2024, the average trading volume of OPRX was 136.67K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
OPRX) stock’s latest price update
OptimizeRx Corp (NASDAQ: OPRX) has experienced a decline in its stock price by -31.71 compared to its previous closing price of 6.15. However, the company has seen a fall of -33.01% in its stock price over the last five trading days. seekingalpha.com reported 2024-11-13 that OptimizeRx Corporation (NASDAQ:OPRX ) Q3 2024 Results Earnings Conference Call November 13, 2024 4:30 PM ET Company Participants William Febbo – Chief Executive Officer Edward Stelmakh – Chief Financial Officer and Chief Operational Officer Steve Silvestro – President Conference Call Participants Ryan Daniels – William Blair & Company, LLC Sean Dodge – RBC Capital Markets Kyle Bauser – B. Riley Securities David Grossman – Stifel Financial Constantine Davides – Citizens JMP Stephanie Davis – Barclays Operator Good afternoon, everyone, and thank you for joining OptimizeRx’s Third Quarter Fiscal 2024 Earnings Call.
OPRX’s Market Performance
OptimizeRx Corp (OPRX) has experienced a -33.01% fall in stock performance for the past week, with a -35.48% drop in the past month, and a -49.64% drop in the past quarter. The volatility ratio for the week is 11.01%, and the volatility levels for the past 30 days are at 7.44% for OPRX. The simple moving average for the last 20 days is -26.16% for OPRX’s stock, with a simple moving average of -58.91% for the last 200 days.
Analysts’ Opinion of OPRX
Many brokerage firms have already submitted their reports for OPRX stocks, with B. Riley Securities repeating the rating for OPRX by listing it as a “Buy.” The predicted price for OPRX in the upcoming period, according to B. Riley Securities is $18.50 based on the research report published on July 25, 2024 of the current year 2024.
JMP Securities, on the other hand, stated in their research note that they expect to see OPRX reach a price target of $15. The rating they have provided for OPRX stocks is “Mkt Outperform” according to the report published on April 04th, 2024.
Barclays gave a rating of “Equal Weight” to OPRX, setting the target price at $15 in the report published on January 03rd of the current year.
OPRX Trading at -37.08% from the 50-Day Moving Average
After a stumble in the market that brought OPRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -74.77% of loss for the given period.
Volatility was left at 7.44%, however, over the last 30 days, the volatility rate increased by 11.01%, as shares sank -33.11% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -43.47% lower at present.
During the last 5 trading sessions, OPRX fell by -29.59%, which changed the moving average for the period of 200-days by -68.73% in comparison to the 20-day moving average, which settled at $5.70. In addition, OptimizeRx Corp saw -70.65% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OPRX starting from Odence-Ford Marion, who sale 4,000 shares at the price of $15.19 back on Jan 09 ’24. After this action, Odence-Ford Marion now owns 11,114 shares of OptimizeRx Corp, valued at $60,751 using the latest closing price.
Stock Fundamentals for OPRX
Current profitability levels for the company are sitting at:
- -0.32 for the present operating margin
- 0.63 for the gross margin
The net margin for OptimizeRx Corp stands at -0.27. The total capital return value is set at -0.19. Equity return is now at value -15.13, with -12.18 for asset returns.
Based on OptimizeRx Corp (OPRX), the company’s capital structure generated 0.24 points at debt to capital in total, while cash flow to debt ratio is standing at -0.04. The debt to equity ratio resting at 0.31. The interest coverage ratio of the stock is 8.99.
Currently, EBITDA for the company is -21.31 million with net debt to EBITDA at -0.67. When we switch over and look at the enterprise to sales, we see a ratio of 1.05. The receivables turnover for the company is 3.35for trailing twelve months and the total asset turnover is 0.53. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.07.
Conclusion
To sum up, OptimizeRx Corp (OPRX) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
